SPECTRAL AI INC C/WTS (TO PUR COM) | 8-K: FY2025 Q2 Revenue: USD 5.065 M

Revenue: As of FY2025 Q2, the actual value is USD 5.065 M.

EPS: As of FY2025 Q2, the actual value is USD -0.31.

Research & Development Revenue

• Q2 2025: $5.1 million, a decline of 32.0% from $7.5 million in Q2 2024, due to the completion of clinical trial and other reimbursed study costs in 2024 under the BARDA PBS Contract.
• First half of 2025: $11.8 million.

Gross Margin

• Q2 2025: 45.2%, slightly down from 46.6% in Q2 2024, due to higher non-reimbursed expenses attributed to the BARDA PBS Contract.

General & Administrative Expense

• Q2 2025: $4.4 million, down from $5.8 million in Q2 2024, reflecting the company’s focus on operating efficiencies.

Other Income/(Expense)

• Q2 2025: - $5.9 million, a decrease from - $0.4 million in Q2 2024, primarily due to an increase in the fair value of the company’s warrant liability by - $5.4 million.

Net Income/(Loss)

• Q2 2025: Net loss of - $7.9 million, compared to a net loss of - $2.9 million in Q2 2024, primarily due to the change in the fair value of the company’s warrant liability.
• First six months of 2025: Net loss of - $5.1 million, a 16.4% reduction from the net loss of - $6.1 million in the first six months of 2024, reflecting the company’s focus on managing operating expenses.

Financial Condition

• As of June 30, 2025: Cash position improved to $10.5 million from $5.2 million on December 31, 2024.
• Debt financing agreement of up to $15.0 million from Avenue Capital Group, with an initial drawdown of $8.5 million, and raised approximately $2.7 million of equity financing from institutional and other new and existing investors.

Cash Flow

• Net cash used in operating activities for the first six months of 2025: - $4.9 million, compared to - $8.0 million in the first six months of 2024.
• Net cash provided by financing activities for the first six months of 2025: $10.2 million, compared to $10.1 million in the first six months of 2024.

Outlook / Guidance

• The company reiterates its revenue guidance of approximately $21.5 million for FY 2025, excluding contributions from the sale of the DeepView™ System for the burn indication or any additional material financial contributions from its commercialization.